Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations is a dataset published in Brain (2025). On theSindex it has a DataRank of 0.288, placing it in the top 56.3% of the data-sharing corpus. It has been cited 3 times, with 2 citing works in its 1-hop citation network. Its calibrated FAIR score is 17/100.
Ranks in the top 56% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
The headline score is computed from the scored criteria — the fact-shaped checks (a repository, an accession, a licence) that two independent models agree on. The advisory criteria below are real FAIR guidance but rest on judgment calls that models read differently, so they inform without moving the number.
No persistent identifier (DOI, Handle, repository accession) is given for the study's own dataset; only URLs and general references to data platforms are provided.
RDA-F1-01D — FAIR Data Maturity Model: 'Data is identified by a persistent identifier' (priorit · RDA-F1-02D — FAIR Data Maturity Model: 'Data is identified by a globally unique identifier' · FsF-F1-02D — F-UJI/FAIRsFAIR: 'Data is assigned a persistent identifier'
No proper-noun repository is named as the holder of the study's own data; the text points to consortium platforms and application processes. [majority verdict 'no' (2/5 passes agreed)]
RDA-F4-01M — FAIR Data Maturity Model: metadata is offered so it can be harvested and indexed ( · NIH DMS Policy Element 4 (NOT-OD-21-014) — name the repository where data will be archived · NSTC Desirable Characteristics of Data Repositories (2022) — 'Long-Term Sustainability', 'Reten
“All GP2 data for these analyses is available through collaboration with Accelerating Medicines Partnership in Parkinson’s disease (AMP-PD) initiative. The GP2-BLAAC PD, NPDRN, and PDGENE datasets are all accessible via GP2 (release version 7 and version 8), available through application on the AMP-PD platform (https://amp-pd.org/register-for-amp-pd). Other publicly available data consortiums include All of Us Research Program (https://www.researchallofus.org/register/) and UK Biobank (https://www.ukbiobank.ac.uk/enable-your-research/register), in which data can be accessed after applying.”— not found in the paper; verdict downgraded
The dataset's identifier (GP2 release version) appears only in the body text (data availability section), not as a reference-list entry. [downgraded to 'no' — no verifiable quote from the paper] [majority verdict 'no' (4/5 passes agreed)]
FORCE11 Joint Declaration of Data Citation Principles (2014) — data should be cited as a first- · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes · FsF-F3-01M — F-UJI: 'Metadata includes the identifier of the data it describes'
Advisory · not in the published score
“All GP2 data for these analyses is available through collaboration with Accelerating Medicines Partnership in Parkinson’s disease (AMP-PD) initiative . The GP2-BLAAC PD, NPDRN, and PDGENE datasets are all accessible via GP2 (release version 7 and version 8), available through application on the AMP-PD platform (https://amp-pd.org/register-for-amp-pd ). Other publicly available data consortiums include All of Us Research Program (https://www.researchallofus.org/register/ ) and UK Biobank (https://www.ukbiobank.ac.uk/enable-your-research/register ), in which data can be accessed after applying.”— not found in the paper; verdict downgraded
The statement points to a platform that requires application and carries no accession or DOI, so it is not a repository record. [downgraded to 'no' — no verifiable quote from the paper] [majority verdict 'no' (3/5 passes agreed)]
Colavizza, Hrynaszkiewicz, Staden, Whitaker & McGillivray (2020), 'The citation advantage of li · Springer Nature research data policy — Data Availability Statements: standard statement templat · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes
“We identified 443 rare variants, including 105 in eight PD genes and 338 in genes associated with parkinsonism or other neurodegenerative diseases (Supplementary Table 2).”— not found in the paper; verdict downgraded
The dataset's content is stated in a running prose sentence, not in an itemised inventory section, table, or list. [downgraded to 'no' — no verifiable quote from the paper] [majority verdict 'no' (3/5 passes agreed)]
RDA-F2-01M — 'Rich metadata is provided to allow discovery' (priority Essential) · FsF-F2-01M — F-UJI: 'Metadata includes descriptive core elements to support data findability' · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data'
“available through application on the AMP-PD platform (https://amp-pd.org/register-for-amp-pd)”— not found in the paper; verdict downgraded
The access route carries a precondition (application and approval), not unconditional availability. [downgraded to 'no' — no verifiable quote from the paper] [majority verdict 'no' (3/5 passes agreed)]
RDA-A1.1-01D — 'Data is accessible through a free access protocol' · FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · NSTC Desirable Characteristics of Data Repositories (2022) — 'Free and Easy Access'
Advisory · not in the published score
“The text does not use any standard access-level label such as 'open access', 'restricted access', or 'embargoed' for the data. It only describes the application process.”— not found in the paper; verdict downgraded
No access-level label is applied to the data; the paper only describes the application process. [majority verdict 'no' (4/5 passes agreed)]
FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · RDA-A1-01M — metadata contains information to enable the user to get access to the data · COAR Controlled Vocabularies — Access Rights v1.0 (open / embargoed / restricted / metadata-onl
“All GP2 data for these analyses is available through collaboration with Accelerating Medicines Partnership in Parkinson’s disease (AMP-PD) initiative.”— not found in the paper; verdict downgraded
The paper names institutional gatekeepers: AMP-PD, All of Us, and UK Biobank are controlled-access repositories. [downgraded to 'partial' — no verifiable quote from the paper] [majority verdict 'partial' (3/5 passes agreed)]
NIH Genomic Data Sharing Policy (NOT-OD-14-124) — controlled-access via a Data Access Committee · RDA-A1.2-01D — 'Data is accessible through an access protocol that supports authentication and · NIH DMS Policy Element 5 (NOT-OD-21-014) — Access, Distribution, or Reuse Considerations (conse
The paper says nothing about how long the data will be retained or when they become available; no temporal commitment is made.
NIH DMS Plan Element 4 (NOT-OD-21-014) — Data Preservation, Access, and Associated Timelines · NSTC Desirable Characteristics (2022), Organizational Infrastructure: 'Retention Policy' · RDA-A2-01M — 'Metadata is guaranteed to remain available after data is no longer available'
No file format for the released data is named anywhere in the text.
FsF-R1.3-02D — F-UJI: 'Data is available in a file format recommended by the target research co · RDA-R1.3-02D — data is expressed in a machine-understandable community standard · RDA-I1-01D — data uses a knowledge representation expressed in a standardised format
Advisory · not in the published score
No community data or metadata standard (e.g., MIAME, MINSEQE, BIDS) is named for the released dataset.
RDA-R1.3-01M — 'Metadata complies with a community standard' (priority Essential) · RDA-R1.3-01D — 'Data complies with a community standard' · RDA-I2-01M — '(Meta)data use vocabularies that follow FAIR principles'
“NCT04057794, NCT04994015”— not found in the paper; verdict downgraded
The paper includes clinical trial identifiers for the PDGENE study, which are identifiers for a resource other than the paper's own dataset. [downgraded to 'no' — no verifiable quote from the paper] [majority verdict 'no' (3/5 passes agreed)]
RDA-I3-01M — '(meta)data include references to other (meta)data' · RDA-I3-03M — 'metadata includes qualified references to other metadata' · FsF-I3-01M — F-UJI: 'Metadata includes links between the data and its related entities'
No licence for the data is stated; the CC BY 4.0 licence applies only to the article, not the data.
RDA-R1.1-01M — 'Metadata includes information about the licence under which the data can be reu · RDA-R1.1-02M — 'Metadata refers to a standard reuse licence' · RDA-R1.1-03M — 'Metadata refers to a machine-understandable reuse licence'
“release version 7 and version 8”
The paper identifies the dataset snapshot by a version token (GP2 release version 7 and version 8). [majority verdict 'yes' (3/5 passes agreed)]
DataCite Metadata Schema 4.6 — the 'Version' property · RDA-R1.2-01M — provenance information (which version was used is provenance) · NSTC Desirable Characteristics of Data Repositories (2022) — 'Provenance', 'Retention Policy'
“DOI 10.5281/zenodo.14579574”
The paper provides a machine-resolvable DOI for the code repository, meeting the class-1 criterion. [majority verdict 'yes' (3/5 passes agreed)]
NIH DMS Policy Element 2 (NOT-OD-21-014) — 'Related Tools, Software and/or Code' · FAIR4RS Principles v1.0 (Chue Hong et al., 2022; RDA/FORCE11/ReSA) — FAIR Principles for Resear · FORCE11 Software Citation Principles (Smith, Katz & Niemeyer, 2016, PeerJ CS 2:e86)
“ZO1 AG000535”
An award number (ZO1 AG000535) is given, attached to a named funder (National Institute on Aging). [majority verdict 'yes' (4/5 passes agreed)]
DataCite Metadata Schema 4.6 — 'FundingReference' property (funderName, funderIdentifier, award · Crossref Funder Registry — canonical funder identifiers for funding metadata · RDA-F2-01M — rich metadata provided to allow discovery (funding is part of the descriptive reco
Advisory · not in the published score
“Gauchian targeted caller”
The paper names specific software tools used to produce the data (e.g., Gauchian, ANNOVAR). [majority verdict 'yes' (3/5 passes agreed)]
RDA-R1.2-01M — 'Metadata includes provenance information according to community- specific standa · FsF-R1.2-01M — F-UJI: 'Metadata includes provenance information about data creation or generati · W3C PROV-O (W3C Recommendation, 2013) — the entity/activity/agent model of provenance
“Table 1 Known pathogenic or likely pathogenic variants identified in Parkinson’s disease genes”
Variable definitions (variant table) are inside the article; no separate documentation object shipped with the data is mentioned. [majority verdict 'partial' (3/5 passes agreed)]
RDA-R1-01M — '(Meta)data are richly described with a plurality of accurate and relevant attribu · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data' · NIH DMS Policy Element 3 (NOT-OD-21-014) — Standards (documentation and metadata to accompany t
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0.0802
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
Department of Health and Human Services
Grant: ZO1 AG000535
Department of Health and Human Services
Grant: AG000949
National Institute of Neurological Disorders and Stroke
Grant: ZIANS003154
NIH STRIDES
Grant: OT2OD032100
NIH STRIDES
Grant: OT2OD027060
NIH STRIDES
Grant: OT2OD027852
Michael J. Fox Foundation for Parkinson’s Research
Grant: MJFF-009421/17483
Michael J. Fox Foundation
Grant: MJFF-026283
ADSP
Grant: 5U01AG076482-03
Alzheimer's Disease Sequencing Project
National Institutes of Health
Global Parkinson's Genetics Program
Global Parkinson’s Genetics Program
Michael J. Fox Foundation and Aligning Sciences Across Parkinson’s Disease Global Parkinson Genetic Program
NIA
NIA NIH HHS
NIH
Aligning Science Across Parkinson’s
NIH HHS
NIH HPC Biowulf cluster
Aligning Science Across Parkinson's
Intramural Research Program
Alzheimer's Disease Sequencing Project
Michael J. Fox Foundation and Aligning Sciences Across Parkinson's Disease Global Parkinson Genetic Program
NHGRI NIH HHS
National Institute on Aging
National Human Genome Research Institute
NIH HPC Biowulf cluster
Intramural Research Program
NIH
NIA NIH HHS
NIA
NIH HHS
NHGRI NIH HHS
Global Parkinson's Genetics Program
Aligning Science Across Parkinson's
Michael J. Fox Foundation and Aligning Sciences Across Parkinson's Disease Global Parkinson Genetic Program
Alzheimer's Disease Sequencing Project
Fields of Study
MeSH Terms
Keywords